ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,521.52
-1.39%
Dow Jones
40,813.57
-1.30%
US Dollar vs MXN
20.1051
0.09%
Brent Oil
70.085
0.23%
Bitcoin
81,820.64
0.97%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Novonesis AS (PK) (NVZMF) Cotización

Novonesis AS (PK)

Novonesis AS (PK) (NVZMF)

USOTC
61.344
4.71
(8.32%)
Cerrado 14 Marzo 2:00PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
61.344
Postura de Compra
35.24
Postura de Venta
81.34
Volume Operado de la Acción
431
58.846 Rango del Día 61.344
52.51 Rango de 52 semanas 71.518
Capitalización de Mercado [m]
25.43B
Precio Anterior
56.63
Precio de Apertura
58.846
Hora
31
@
61.344
Última hora de negociación
Volumen financiero
US$ 25,440
Precio Promedio Ponderado
59.0257
Volumen promedio (3 m)
674
Acciones en circulación
414,555,046
Rendimiento del Dividendo
69.55%
Ratio Precio/Utilidad
7.53
Beneficio por acción (BPA)
7.29
turnover
17.9B
Beneficio neto
3.02B

Acerca de Novonesis AS (PK)

Sector
Pharmaceutical Preparations
Industria
Medicinal Chems,botanicl Pds
Sitio web
www.novonesis.com
Sede
Kongens Lyngby, Dnk
Fundado
1999
Novonesis AS (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NVZMF. The last closing price for Novonesis AS (PK) was US$56.63. Over the last year, Novonesis AS (PK) shares have traded in a share price range of US$ 52.51 to US$ 71.518.

Novonesis AS (PK) currently has 414,555,046 shares in issue. The market capitalisation of Novonesis AS (PK) is US$23.48 billion. Novonesis AS (PK) has a price to earnings ratio (PE ratio) of 7.53.

NVZMF Últimas noticias

Más noticias
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
14.3447.621052631585761.34456.63139756.77406015CS
45.1449.1530249110356.263.35253.657857.75253123CS
122.6944.5933503836358.6563.35253.5567456.45664647CS
26-8.586-12.27799227869.9371.51853.5574459.20420226CS
522.5544.3442762374658.7971.51852.5171360.06553041CS
1561.8993.1945495836559.44571.51838.158266163052.71439271CS
26017.87441.118012422443.4782.5935.25150955.32599808CS

NVZMF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Novonesis AS (PK)?
El precio actual de las acciones de Novonesis AS (PK) es US$ 61.344
¿Cuántas acciones de Novonesis AS (PK) están en circulación?
Novonesis AS (PK) tiene 414,555,046 acciones en circulación
¿Cuál es la capitalización de mercado de Novonesis AS (PK)?
La capitalización de mercado de Novonesis AS (PK) es USD 23.48B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Novonesis AS (PK)?
Novonesis AS (PK) ha negociado en un rango de US$ 52.51 a US$ 71.518 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Novonesis AS (PK)?
El ratio precio/beneficio de Novonesis AS (PK) es 7.53
¿Cuál es el ratio de efectivo a ventas de Novonesis AS (PK)?
El ratio de efectivo a ventas de Novonesis AS (PK) es 1.27
¿Cuál es la moneda de reporte de Novonesis AS (PK)?
Novonesis AS (PK) presenta sus resultados financieros en DKK
¿Cuál es el último ingresos anual de Novonesis AS (PK)?
El último ingresos anual de Novonesis AS (PK) es DKK 17.9B
¿Cuál es el último beneficio anual de Novonesis AS (PK)?
El último beneficio anual de Novonesis AS (PK) es DKK 3.02B
¿Cuál es la dirección registrada de Novonesis AS (PK)?
La dirección registrada de Novonesis AS (PK) es BIOLOGIENS VEJ 2, KONGENS LYNGBY, 2800
¿Cuál es la dirección del sitio web de Novonesis AS (PK)?
La dirección del sitio web de Novonesis AS (PK) es www.novonesis.com
¿En qué sector industrial opera Novonesis AS (PK)?
Novonesis AS (PK) opera en el sector MEDICINAL CHEMS,BOTANICL PDS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
100
ZHCLFZenith Capital Corporation (CE)
US$ 0.05
(49,900.00%)
2k
AGRDFMinnova Corporation (PK)
US$ 0.035
(34,900.00%)
30.3k
CMGRClubhouse Media Group Inc (CE)
US$ 0.0002
(19,900.00%)
5k
AXCPAllixon International Corporation (CE)
US$ 0.0002
(19,900.00%)
100
WOWIMetro One Telecommunications Inc (CE)
US$ 0.000001
(-99.94%)
100
LRKKFLark Distilling Company Ltd (PK)
US$ 0.0015
(-99.81%)
1,000
DUGTFDug Technology Ltd (PK)
US$ 0.0043
(-99.75%)
100
CLVRClever Leaves Holdings Inc (CE)
US$ 0.000001
(-99.50%)
1.16k
BLSPBlue Sphere Corporation (CE)
US$ 0.000001
(-99.00%)
344k
ASIIAccredited Solutions Inc (PK)
US$ 0.0003
(-25.00%)
267.36M
GRLTGrillit Inc (PK)
US$ 0.00065
(-27.78%)
248.88M
HMBLHUMBL Inc (PK)
US$ 0.00035
(0.00%)
180.42M
TPTWTPT Global Tech Inc (PK)
US$ 0.0002
(0.00%)
147.36M
NNAXNew Momentum Corporation (PK)
US$ 0.0007
(27.27%)
128.2M

Discusión

Ver feed completo
JohnnyHydrogen JohnnyHydrogen 4 minutos hace
Good Article about CMM tax credit to be added to 45Q!

https://www.forbes.com/sites/taxnotes/2024/10/28/energy-tax-credit-changes-begin-to-line-up-for-2025/

The article is written shortly before the election, so obviously things have changed for the better as far as Coal
FCEL
LovePennyStock LovePennyStock 5 minutos hace
I believe the uptrend is not done yet. Annual meeting announced on 21 March. If we get some good news, the share price should enter the new higher range between $4-$9. I still think we will see the uptrend continuing for next week. Let's go, QMMM !!!!!!!!
QMMM
stocktank2020 stocktank2020 7 minutos hace
Finally someone else sees it but honestly who cares what wagon they decided to hitch their shady marketing to this time as long as it leads to Zeranovia units moved and people buy the stock. We just need to time the exit right before the big dump.
BDPT
Hoghead7 Hoghead7 7 minutos hace
FYI, should be aware of short attacks. Henrique is a self professed short targeted FCEL for at least 5 years. Always writing very bearish articles. He mentions a few facts and a couple + issues just because they are undeniable, usually numbers they reported, and always with something inaccurate.
FCEL
lovethatgreen lovethatgreen 8 minutos hace
Hearing from where exsctly . Considering that makes absolutely no logical sense .
AZRH
BDEZ BDEZ 8 minutos hace
‘They slaughtered us like fish in a barrel’—citizen reporter exposes Vegas massacre coverup

https://revolver.news/2025/03/they-slaughtered-us-like-fish-in-a-barrel-citizen-reporter-exposes-vegas-massacre-coverup/
XMaster2023 XMaster2023 11 minutos hace
Merck Unveils New Facility to Increase Vaccine Production Capacity
Opening highlights effort to expand U.S. manufacturing through a $1 billion investment

March 11, 2025 06:45 AM Eastern Daylight Time
DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside
MRK
BDEZ BDEZ 15 minutos hace
This is clearly a racially motivated attack! Warning Graphic video: A small child was jumped and viciously beaten by a mob in Baltimore. The child was repeatedly stomped and punched, and was stripped of his clothing.

5 teens have reportedly been charged but police are saying this is N
janice shell janice shell 17 minutos hace
DJT is making America dangerously vulnerable, not "great again".

Good for you, Renee! Canada's always been a good neighbor. And as you say, it's taken the spoiled attention-seeker masquerading as president less than two months to stir up a great deal of enmity with his foolishness.
DJT
gimmee greenbacks gimmee greenbacks 18 minutos hace
https://alaction.it/

ITALY



BIEL
BIEL
manibiotech manibiotech 22 minutos hace
In simpler terms for you -15% of what ?
What's the total amount ?
All unknown . 
You can go on long tirade all you want , fact is you can't provide shred of evidence on either . It's like saying I will build your home for cost + 15% . But I won't tell you what the total cost is
NWBO
Panzer Panzer 23 minutos hace
Gold 3K 💥 
RITE
getmenews getmenews 27 minutos hace
Trump-backed World Liberty Financial completes $550 million token sale
March 13 2025 - 11:02PM

Nice day!
BTCUSD
manibiotech manibiotech 29 minutos hace
lol cost + 15 is like saying Y = x+15
Now mind telling us either of the x or y variables if you know elementary math and do provide a link .
NWBO
Renee Renee 31 minutos hace
I usually bide my tongue, but after proudly displaying co-joined U.S. and Canadian flags in my profile for 12 years I removed the co-joined flags in absolute disgust at the way DJT is treating all of Canada. He is treating Canada as an arch enemy.

I am sick of hearing DJT accusing Can
DJT
arizona1 arizona1 32 minutos hace
I don't know crushie. You sound a little defensive. Is this conversation hitting a tad too close to home for you?

Totally normal! lolol

This one is especially creepy.

https://imageio.forbes.com/specials-images/imageserve/bbbcc00affe39bc8854449e57afe139
axelvento axelvento 32 minutos hace
Making a Mark: Local vaccine trial taking personal approach to treating kidney cancer

Researchers have partnered with Merck and Moderna on the study

NEW HAVEN, CT. (WFSB) - When it comes to treating and beating cancer, the same approach doesn’t always work for every pat
MRNA
navycmdr navycmdr 33 minutos hace
It's really spreading bigly ....
https://investorshub.advfn.com/uimage/uploads/2025/3/14/dypyvScreenshot_20250313_213842_X.jpg
FNMA
theswordman theswordman 34 minutos hace
For Bioxytran--Board of Directors David Platt
PHD CEO & CHAIRMAN OF THE BOARD
For Heme Guy Platt Board Member

For BIXT-- Mike Sheikh Chief Communication Officier --Notice ZERO mention of his Resources Unlimited company and his affiliation/prev works with Cytodyn
GLP
manibiotech manibiotech 34 minutos hace
Who else does Advent provide those skill sets 
?
Who else provides their revenue?

I will let the board decide who is ridiculous 
NWBO
Fangster Fangster 35 minutos hace
Yes, your CVSI just just killing it!  Have you given up listening to the two grifters on that board? 
CVSI
norisknorewards norisknorewards 36 minutos hace
Lmao. And I'm called a short cause folks can't understand my grammar. Priceless beyond belief.

What a disaster of a post of incoherency
NWBO
axelvento axelvento 39 minutos hace
Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season

https://www.fda.gov/vaccines-blood-biologics/influenza-vaccine-composition-2025-2026-us-influenza-season

$MRNA
MRNA
MC10459 MC10459 40 minutos hace
What's better than the best posterer? A postererer.
HMBL
spdpro spdpro 41 minutos hace
and >
https://www.zerohedge.com/crypto/senate-banking-committee-advances-genius-stablecoin-bill-despite-banking-pushback

Su Consulta Reciente

USOTC
NVZMF
Novonesis AS (PK)
COIN
CPOOLUSD
Clearpool
COIN
DEPAYUSD
DePay
USOTC
TLLXY
Talanx (PK)
BIT
S32119
Societe Generale Effekten
BIT
PA0392
Bnp Paribas Issuance
COIN
SUNETH
SUN TOKEN
BIT
UC46C6
Unicredit Bank
AQEU
MONCM
Moncler
USOTC
IHSXF
Ishares PLC Ishares MSCI... (PK)
AQEU
CATGP
Catana
BIT
UB3ZF0
Unicredit Bank
USOTC
IMCDY
IMCD Group NV (PK)
BIT
F34679
Vontobel Financial Produ...
USOTC
DLVHF
Delivery Hero AG NA (PK)
USOTC
TMTNF
Toromont Inds Ltd Cda (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios